Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report
Li Liu,Jie Chen,Kangheng Tang,Feng Li,Si Li,Xiaojie Ding
DOI: https://doi.org/10.2147/CCID.S420904
2023-08-15
Abstract:Li Liu, &ast Jie Chen, &ast Kangheng Tang, Feng Li, Si Li, Xiaojie Ding Department of Dermatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaojie Ding, Department of Dermatology, Affiliated Hospital of North Sichuan Medical College, 1st Maoyuan South Road, Shunqing District, Nanchong, Sichuan Province, 637000, People's Republic of China, Tel +8615881788808, Fax +8681715881788808, Email Psoriasis and atopic dermatitis are relatively common in clinical practice, but it is rare for the two diseases to co-occur in the same patient. Dupilumab, an anti-IL-4/IL-13 monoclonal antibody, has been approved for treating moderate to severe AD. In addition to its therapeutic effects, dupilumab may induce new cutaneous adverse reactions. We report a rare case of pustular psoriasis induced during the treatment of atopic dermatitis with dupilumab. This case demonstrates the need for caution while treating patients with moderate to severe atopic dermatitis and staying vigilant for the emergence of new symptoms, especially with biological agents. Keywords: psoriasis, atopic dermatitis, dupilumab, case report A 13-year-old male child presented to our department in January 2023 with recurrent erythema, papules, vesicles, and oozing accompanied by generalized pruritus for three years. The patient had erythema and papules on the trunk and extremities with no obvious cause three years ago, and after scratching, he developed vesicles, oozing, and crusting. He was diagnosed with atopic dermatitis after several visits to our hospital and other hospitals. The patient's dermatitis failed to improve after receiving oral anti-allergic and topical steroids: the lesions and itching worsened and seriously affected his quality of life and study, so he revisited our department. He was diagnosed with severe atopic dermatitis upon evaluation and was treated with dupilumab 400 mg subcutaneously, but the lesions worsened, with the appearance of white corn-shaped pustules scattered on his trunk and extremities. We learned through consultation that the patient had a six-year history of allergic rhinitis; his father also had a history of allergic rhinitis, but his mother was healthy. On dermatological examination, diffuse erythema, papules, scales, and mossy plaques were visible on the trunk and extremities, with localized vesicles and exudation. We observed generalized dry skin and a few scattered corn-sized white pustules on the trunk and lower extremities. The patient's severity of atopic dermatitis score was 80.2 (mild: 0–24; moderate: 25–50; and severe >50) (Figures 1 and 2). Laboratory tests revealed leukocytosis (33,040/μL) with neutrophilia (97,000/μL) and elevated erythrocyte sedimentation rate to improve. Notably, immunoglobulin E (6010IU/mL) and eosinophils (1676/μL, 59.1%) were also elevated. The suggested allergens were house dust mite (>100IU/mL), egg (1.26IU/mL), wheat (0.42IU/mL), and house dust (1.02IU/mL). Based on the appearance of corn-sized white pustules on the trunk and lower extremities of the child, we suspected a new skin disease. Consequently, we performed a dermatopathological biopsy of the white pustules on the child's abdomen. The biopsy results suggested epidermal hyperkeratosis with fused dyskeratosis, neutrophilic microabscesses in the dyskeratotic stratum corneum, reduced or even absent granular layer beneath the dyskeratosis, hypertrophy of the spinous layer, upwardly displaced dermal papillae, dilated capillaries, superficial perivascular lymphocytes, and scattered neutrophil infiltration (Figure 3). Figure 1 ( A and B ) Typical AD lesions on both lower extremities and trunk. Figure 2 ( A and B ) White pustules on the lower extremities and trunk (red arrow in ( A and B )). Figure 3 Anatomopathological examination of white pustules revealed epidermal hyperkeratosis with fused dyskeratosis, neutrophilic microabscesses in the dyskeratotic stratum corneum, reduced or even absent granular layer beneath the dyskeratosis, hypertrophy of the spinous layer, upwardly displaced dermal papillae, dilated capillaries, superficial perivascular lymphocytes, and scattered neutrophil infiltration (HEx40). Finally, the child was diagnosed with pustular psoriasis based on his prolonged history of illness for more than six months, clinical presentation, family history, laboratory tests, and histopathological biopsy results. Consequently, we discontinued dupilumab, and the child was continued on anti-allergic and topical moisturizing emollient treatment. The erythematous papules and pruritus reduced co -Abstract Truncated-
dermatology